Insider Transactions in Q2 2024 at Bright Health Group Inc. (BHG)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2024
|
Jeffrey R Immelt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+26.16%
|
-
|
|
May 12
2024
|
Manuel Kadre Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+19.75%
|
-
|
|
May 12
2024
|
Stephen Kraus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+44.44%
|
-
|
|
May 12
2024
|
Matthew G Manders Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+43.24%
|
-
|
|
May 12
2024
|
Robert J Sheehy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+50.0%
|
-
|
|
May 12
2024
|
Mohamad Makhzoumi |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+44.45%
|
-
|
|
May 12
2024
|
Linda R Gooden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+4.55%
|
-
|
|
May 12
2024
|
Kedrick D Adkins Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+4.55%
|
-
|
|
May 12
2024
|
Andrew M Slavitt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+37.19%
|
-
|
|
May 10
2024
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
113
-2.99%
|
$678
$6.05 P/Share
|
|
May 10
2024
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
317
-3.29%
|
$1,902
$6.05 P/Share
|
|
May 09
2024
|
Jeffrey J Scherman Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
343
+8.31%
|
-
|
|
May 09
2024
|
Jay Matushak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
978
+9.23%
|
-
|